Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGDE-crosslinked hyaluronic acid hydrogel (Stimulate) for midface volume/contour deficiency
NCT07359079Active, not recruiting
- Start
- Mar 2025
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of Stimulate (2 arms). Primary endpoint: Effectiveness Rate of Improvement for Midface Volume Deficiency and/or Midface Contour Deficiency at 6 months. Started Mar 2025; status: active, not recruiting.
02
Drugs
Stimulate
Beyond the preview
Go deeper on NCT07359079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07359079.